1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Lumacaftor 200 MG: new trials by email Literature Review of Lumacaftor 200 MG trials Research Report on Lumacaftor 200 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients Lumacaftor 200 MG, Placebo - Heart Failure With Reduced Ejection Fraction | Phase 2 | Recruiting | Qanatpharma AG | 60 | 2026-07-01 | 2026-07-17 |
Qanatpharma AG (1)
Canada (1)
Kim Connelly (1)